The comments of Anne Robert, Emmanuel Gras, Peter Faller, and Guy Lavigne of CNRS-LCC are gratefully acknowledged.
1521-3773/asset/2002_left.gif?v=1&s=ac6b0d94a94d7ce7a210002b8096b42feffc0bcf)
1521-3773/asset/olbannercenter.gif?v=1&s=c083e1920cd41ed129901c116018eab93b5ad3c4)
1521-3773/asset/2002_right.gif?v=1&s=451042aa3415ae3ad0729984d26dee1866aca82e)
Essay
Does Chemistry Have a Future in Therapeutic Innovations?†
Article first published online: 6 JUL 2012
DOI: 10.1002/anie.201202506
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Meunier, B. (2012), Does Chemistry Have a Future in Therapeutic Innovations? . Angew. Chem. Int. Ed., 51: 8702–8706. doi: 10.1002/anie.201202506
- †
Publication History
- Issue published online: 22 AUG 2012
- Article first published online: 6 JUL 2012
- Manuscript Received: 30 MAR 2012
Funded by
- CNRS-LCC
- Abstract
- Article
- References
- Cited By
Keywords:
- biopharmaceuticals;
- drug development;
- medicinal chemistry;
- therapeutic innovation
A bright future for small molecules: Drugs based on molecules made by chemists are far from old-fashioned. Although biopharmaceuticals developed during the last two decades may have caught the public's imagination, traditional drugs remain a strong force in the pharmaceutical industry. Effective, inexpensive small-molecule drugs are crucial in fighting diseases and maintaining cost-effective health care.